Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.76 |
| ▸ | GLA | P06280 | 7/20 | 0.76 |
| ▸ | GAA | P10253 | 5/20 | 0.76 |
| ▸ | HPGD | P15428 | 5/20 | 0.76 |
| ▸ | MAOB | P27338 | 3/20 | 0.70 |
| ▸ | PPARG | P37231 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | MAOA | P21397 | 2/20 | 0.60 |
| ▸ | MIF | P14174 | 1/20 | 0.60 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | CASP1 | P29466 | 1/20 | 0.57 |
| ▸ | CASP7 | P55210 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2510780 | 0.89 | ALDH1A1 (0.65) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL1710937 | 0.89 | ALDH1A1 (0.65) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL1710778 | 0.89 | MAOB (0.67) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL2510193 | 0.89 | ALDH1A1 (0.65) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL2508919 | 0.87 | ALDH1A1 (0.62) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL2505053 | 0.87 | ALDH1A1 (0.62) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL2508806 | 0.87 | MAOB (0.64) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL1710766 | 0.87 | ALDH1A1 (0.62) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL1711145 | 0.87 | ALDH1A1 (0.62) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL2807607 | 0.87 | ALDH1A1 (1.00) | ALDH1A1KDM4EGLAGAAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022044759-A1 | COMPOSITION CONTAINING SEMICONDUCTOR NANOPARTICLES, COLOR FILTER, AND IMAGE DISPLAY DEVICE | 三菱ケミカル株式会社 | 2022-03-03 | — | — | WO | disclosed |
| US-20200270216-A1 | COMPOSITIONS AND METHODS FOR INHIBITING N-SMASE2 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-08-27 | — | — | US | disclosed |
| EP-2695930-B1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE, NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE | DAINIPPON INK & CHEMICALS (JP) | 2019-09-11 | — | — | EP | disclosed |
| WO-2019055832-A1 | COMPOSITIONS AND METHODS FOR INHIBITING N-SMASE2 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-03-21 | — | — | WO | disclosed |
| US-9951034-B2 | 3-ketocoumarines for LED photocuring | IGM RESINS ITALIA S.R.L. (IT) | 2018-04-24 | — | — | US | disclosed |
| US-9475991-B2 | Polymerizable liquid crystal composition, polarized light-emitting coating material, novel naphtholactam derivative novel coumarin derivative, novel nile red derivative, and novel anthracene derivative | ADEKA CORPORATION (JP) | 2016-10-25 | — | — | US | disclosed |
| US-9475991-B2 | Polymerizable liquid crystal composition, polarized light-emitting coating material, novel naphtholactam derivative novel coumarin derivative, novel nile red derivative, and novel anthracene derivative | ADEKA CORPORATION (JP) | 2016-10-25 | — | — | US | disclosed |
| EP-2344462-B1 | PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | UNIV DUNDEE (GB) | 2016-05-18 | — | — | EP | disclosed |
| US-20130334461-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE | ADEKA CORPORATION (JP) | 2013-12-19 | — | — | US | disclosed |
| US-20130334461-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE | ADEKA CORPORATION (JP) | 2013-12-19 | — | — | US | disclosed |
| US-20110245282-A1 | Compounds | University Court of the University of Dundee University Court of the University of St. Andrews | 2011-10-06 | — | — | US | disclosed |
| US-20110245282-A1 | Compounds | University Court of the University of Dundee University Court of the University of St. Andrews | 2011-10-06 | — | — | US | disclosed |
| US-20110245282-A1 | Compounds | University Court of the University of Dundee University Court of the University of St. Andrews | 2011-10-06 | — | — | US | disclosed |
| EP-2344462-A1 | PYRIMIDE DERIVATIVES AND THEIR PHARMACEUTICAL USE | The University Court of the University of Dundee (GB) | 2011-07-20 | — | — | EP | disclosed |
| WO-2010038043-A1 | PYRIMIDE DERIVATIVES AND THEIR PHARMACEUTICAL USE | THE UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) | 2010-04-08 | — | — | WO | disclosed |
| WO-2010038043-A1 | PYRIMIDE DERIVATIVES AND THEIR PHARMACEUTICAL USE | THE UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) | 2010-04-08 | — | — | WO | disclosed |
| US-7514406-B2 | Methods for inhibiting deacetylase activity | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2009-04-07 | — | — | US | disclosed |
| US-7514406-B2 | Methods for inhibiting deacetylase activity | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2009-04-07 | — | — | US | disclosed |
| WO-2003046207-A2 | METHODS FOR INHIBITING DEACETYLASE ACTIVITY | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2003-06-05 | — | — | WO | disclosed |
| EP-0276016-A2 | Photopolymerizable composition | Nippon Paint Co., Ltd. (JP) | 1988-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245282-A1 | Compounds | NAT1, AR, ARSA | ALDH1A1 1954/4885KDM4E 3359/4885GLA 1050/4885 |
| US-20200270216-A1 | COMPOSITIONS AND METHODS FOR INHIBITING N-SMASE2 | SMN1; SMN2, PSEN2, SMPD2 | ALDH1A1 3977/4885KDM4E 3643/4885GLA 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.